HEMOLYTIC DISEASE OF THE FETUS AND NEWBORN
Clinical trials for HEMOLYTIC DISEASE OF THE FETUS AND NEWBORN explained in plain language.
Never miss a new study
Get alerted when new HEMOLYTIC DISEASE OF THE FETUS AND NEWBORN trials appear
Sign up with your email to follow new studies for HEMOLYTIC DISEASE OF THE FETUS AND NEWBORN, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Breakthrough drug trial aims to stop devastating blood disease in unborn babies
Disease control Recruiting nowThis study is testing an investigational drug called nipocalimab to see if it can prevent severe fetal anemia in pregnant women at high risk for a serious blood condition called Hemolytic Disease of the Fetus and Newborn (HDFN). The goal is to help babies avoid dangerous complica…
Matched conditions: HEMOLYTIC DISEASE OF THE FETUS AND NEWBORN
Phase: PHASE3 • Sponsor: Janssen Research & Development, LLC • Aim: Disease control
Last updated Mar 24, 2026 12:02 UTC
-
Global watchdog launches to track dangerous blood disease in unborn babies
Knowledge-focused Recruiting nowThis study is creating a global registry to collect information on pregnancies at risk for hemolytic disease of the fetus and newborn (HDFN), a serious blood condition in babies. Researchers will follow 175 pregnant participants who are receiving standard medical care to understa…
Matched conditions: HEMOLYTIC DISEASE OF THE FETUS AND NEWBORN
Sponsor: Janssen Research & Development, LLC • Aim: Knowledge-focused
Last updated Apr 04, 2026 01:05 UTC